{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:32:53Z","timestamp":1789471973042,"version":"build-2803163510"},"reference-count":39,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2019,6,23]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the demographics, aetiologies, complications, treatments and visual prognoses of chronic and recurrent non-infectious paediatric-onset uveitis in France.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Descriptive, retrospective and bicentric study in patients whose disease started before 17 and who were followed up in two centres from January 2010 to May 2017.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 147 patients with 268 affected eyes. Eighty-two had juvenile idiopathic arthritis-associated chronic uveitis, 58 were antinuclear antibody (ANA) positive and 24 were ANA negative, 36 had idiopathic uveitis, 9 had enthesitis-related arthritis-associated uveitis, 9 had sarcoidosis-associated uveitis and 11 had other inflammatory aetiologies. These patients cumulated 161 complications: ocular hypertension, cataract, band keratopathy, macular oedema, optic disk oedema and decreased visual acuity, including permanent visual loss for 31 patients. The most used treatments were corticosteroid (CS) eye drops (82%), systemic CSs (34%), methotrexate (58%) and biologics (38%). At the latest follow-up, 45 patients had achieved remission of uveitis without any treatment, 56 had inactive uveitis on topical steroids and 48 still had active uveitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Paediatric-onset uveitis are associated with a high rate of complications. However, following the introduction of biologics and particularly antitumour necrosis factor alpha antibodies, a significant proportion of uveitis became inactive on or even off treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2019-000933","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T06:45:13Z","timestamp":1565073913000},"page":"e000933","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":46,"title":["Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-1674","authenticated-orcid":false,"given":"Guillaume","family":"Morelle","sequence":"first","affiliation":[{"name":"RAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, H\u00e9matologie et Rhumatologie P\u00e9diatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France"},{"name":"Paris-Descartes University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Centre Hospitalier Universitaire de Rouen, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Uettwiller","sequence":"additional","affiliation":[{"name":"Pediatric Department, CHRU Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[{"name":"RAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, H\u00e9matologie et Rhumatologie P\u00e9diatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France"},{"name":"Paris-Descartes University, Paris, France"},{"name":"Pediatric Department, CHRU Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[{"name":"RAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, H\u00e9matologie et Rhumatologie P\u00e9diatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France"},{"name":"Paris-Descartes University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu P","family":"Robert","sequence":"additional","affiliation":[{"name":"Paris-Descartes University, Paris, France"},{"name":"Ophthalmology Department, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France"},{"name":"COGNAC-G, UMR 8257, CNRS-SSA, Universite Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Monnet","sequence":"additional","affiliation":[{"name":"Paris-Descartes University, Paris, France"},{"name":"Ophthalmology Department, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Reference Center in Rare Diseases, Hopitaux Universitaires Pitie Salpetriere-Charles Foix, Assistance Publique Hopitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Grall-lerosey","sequence":"additional","affiliation":[{"name":"Pediatrics Department, Centre Hospitalier Universitaire de Rouen, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-549X","authenticated-orcid":false,"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[{"name":"RAISE reference centre for rare diseases, IMAGINE Institute, Immunologie, H\u00e9matologie et Rhumatologie P\u00e9diatrique, Hopital universitaire Necker-Enfants malades, Assistance Publique Hopitaux de Paris, Paris, France"},{"name":"Paris-Descartes University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"2025090312085791000_5.2.e000933.1","doi-asserted-by":"publisher","DOI":"10.1080\/09273940802702561"},{"key":"2025090312085791000_5.2.e000933.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.01.044"},{"key":"2025090312085791000_5.2.e000933.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02148-7"},{"key":"2025090312085791000_5.2.e000933.4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.7.879"},{"key":"2025090312085791000_5.2.e000933.5","first-page":"633","article-title":"Epidemiology of uveitis in children over a 10-year period","volume":"31","author":"Clarke","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025090312085791000_5.2.e000933.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.05.002"},{"key":"2025090312085791000_5.2.e000933.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"2025090312085791000_5.2.e000933.8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"2025090312085791000_5.2.e000933.9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.berh.2016.07.005","article-title":"Advancements in the management of uveitis","volume":"30","author":"Schwartzman","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090312085791000_5.2.e000933.10","doi-asserted-by":"crossref","unstructured":"Wentworth BA , Freitas-Neto CA , Foster CS . Management of pediatric uveitis. F1000Prime Rep [Internet], 2014. Available: https:\/\/www-ncbi-nlm-nih-gov.gate2.inist.fr\/pmc\/articles\/PMC4047950\/ [Accessed 7 Mar 2017].","DOI":"10.12703\/P6-41"},{"key":"2025090312085791000_5.2.e000933.11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0248-8663(03)00140-1","article-title":"Uv\u00e9ites chroniques s\u00e9v\u00e8res : classification, d\u00e9marche diagnostique et principes th\u00e9rapeutiques","volume":"24","author":"Bodaghi","year":"2003","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"2025090312085791000_5.2.e000933.12","first-page":"362","article-title":"Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis","volume":"32","author":"Foeldvari","year":"2005","journal-title":"J Rheumatol"},{"key":"2025090312085791000_5.2.e000933.13","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.103721"},{"key":"2025090312085791000_5.2.e000933.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212089"},{"key":"2025090312085791000_5.2.e000933.15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N Engl J Med"},{"key":"2025090312085791000_5.2.e000933.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509852"},{"key":"2025090312085791000_5.2.e000933.17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaophthalmol.2017.0603","article-title":"Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the visual-1 and visual-2 trials","volume":"135","author":"Sheppard","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2025090312085791000_5.2.e000933.18","first-page":"51","article-title":"CEMARA: a Web dynamic application within a N-tier architecture for rare diseases","volume":"136","author":"Messiaen","year":"2008","journal-title":"Stud Health Technol Inform"},{"key":"2025090312085791000_5.2.e000933.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"2025090312085791000_5.2.e000933.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"2025090312085791000_5.2.e000933.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.050609"},{"key":"2025090312085791000_5.2.e000933.22","doi-asserted-by":"publisher","DOI":"10.1080\/080352500750043422"},{"key":"2025090312085791000_5.2.e000933.23","doi-asserted-by":"crossref","unstructured":"Clarke SLN , Sen ES , Ramanan AV . Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J 2016;14.doi:10.1186\/s12969-016-0088-2","DOI":"10.1186\/s12969-016-0088-2"},{"key":"2025090312085791000_5.2.e000933.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2008.10.015"},{"key":"2025090312085791000_5.2.e000933.25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2017.03.052","article-title":"Retrospective study evaluating treatment decisions and outcomes of childhood uveitis not associated with juvenile idiopathic arthritis","volume":"186","author":"Sardar","year":"2017","journal-title":"J Pediatr"},{"key":"2025090312085791000_5.2.e000933.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.01.033"},{"key":"2025090312085791000_5.2.e000933.27","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.4.332"},{"key":"2025090312085791000_5.2.e000933.28","first-page":"1139","article-title":"Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease","volume":"34","author":"Grassi","year":"2007","journal-title":"J Rheumatol"},{"key":"2025090312085791000_5.2.e000933.29","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric noninfectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"2025090312085791000_5.2.e000933.30","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200404000-00003"},{"key":"2025090312085791000_5.2.e000933.31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajo.2017.02.023","article-title":"Risk factors for the development of cataract in children with uveitis","volume":"177","author":"Blum-Hareuveni","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2025090312085791000_5.2.e000933.32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1076\/ocii.9.4.243.3959","article-title":"Uveitis in juvenile arthritis","volume":"9","author":"Berk","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090312085791000_5.2.e000933.33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2016.1247174","article-title":"Complications of uveitis: The northern california epidemiology of uveitis study","volume":"43","author":"Gritz","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090312085791000_5.2.e000933.34","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2000.078005576.x"},{"key":"2025090312085791000_5.2.e000933.35","doi-asserted-by":"crossref","unstructured":"Mercier A-E , Ribeiro E , Korobelnik J-F , et al . Efficacy of anti-tnf-\u03b1 therapy for the treatment of non-infectious uveitis: a retrospective study of 21 patients. Ocul Immunol Inflamm 2016:1\u20138.","DOI":"10.1080\/09273948.2016.1236968"},{"key":"2025090312085791000_5.2.e000933.36","doi-asserted-by":"crossref","unstructured":"Cann M , Ramanan AV , Crawford A , et al . Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy. Pediatr Rheumatol Online J 2018;16.doi:10.1186\/s12969-018-0266-5","DOI":"10.1186\/s12969-018-0266-5"},{"key":"2025090312085791000_5.2.e000933.37","doi-asserted-by":"crossref","unstructured":"Ferrara G , Mastrangelo G , Barone P , et al . Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol 2018;16.doi:10.1186\/s12969-018-0255-8","DOI":"10.1186\/s12969-018-0255-8"},{"key":"2025090312085791000_5.2.e000933.38","doi-asserted-by":"publisher","DOI":"10.1080\/09273940600659393"},{"key":"2025090312085791000_5.2.e000933.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.05.005"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2019-000933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:09:06Z","timestamp":1756926546000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2019-000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,8,5]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/rmdopen-2019-000933"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2019-000933","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}